FDA To Propose Rules For Tobacco, Compounding, INDs, Right To Try

FDA expects to propose a number of significant new rules over the next year that will address tobacco product applications, warnings for cigarette packages and advertisements, annual reporting requirements for investigational new drugs, and requirements for drug products that are deemed difficult to compound. Among the approximately 80 planned proposed and final rules listed by FDA in the Spring 2019 Unified Agenda are a handful of new proposals FDA plans to roll out between August 2019 and March 2020. In...